{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:41:38Z","timestamp":1790419298810,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ctrv.2020.101963","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T11:38:54Z","timestamp":1578915534000},"page":"101963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Breast implant-associated anaplastic large cell lymphoma: A comprehensive review"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-7824","authenticated-orcid":false,"given":"Antonio","family":"Marra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7280-361X","authenticated-orcid":false,"given":"Giulia","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pravettoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Nol\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1781-2518","authenticated-orcid":false,"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2020.101963_b0005","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0010","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumour of Haematopoietic and Lymphoid Tissues, Revised 4th edition. IARC Press, Lyon; 2017."},{"key":"10.1016\/j.ctrv.2020.101963_b0015","article-title":"Advisory Group recommendations on priorities for the IARC monographs","author":"Group IMP","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2020.101963_b0020","unstructured":"US Food and Drug Administration. Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Available at: https:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/ImplantsandProsthetics\/BreastImplants\/ucm481899.htm. Access on 8th April 2019."},{"key":"10.1016\/j.ctrv.2020.101963_b0025","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1097\/PRS.0000000000005567","article-title":"Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants","volume":"143","author":"Collett","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0030","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1097\/PRS.0000000000005571","article-title":"Patient registry and outcomes for breast implants and anaplastic large cell lymphoma etiology and epidemiology (PROFILE): initial report of findings, 2012\u20132018","volume":"143","author":"McCarthy","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0035","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","article-title":"Epidemiology of breast implant-associated anaplastic large cell lymphoma","volume":"139","author":"Doren","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0040","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.2008.585","article-title":"Anaplastic large-cell lymphoma in women with breast implants","volume":"300","author":"de Jong","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ctrv.2020.101963_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","article-title":"Breast implants and the risk of anaplastic large-cell lymphoma in the breast","volume":"4","author":"de Boer","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctrv.2020.101963_b0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/PRS.0000000000001037","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"135","author":"Gidengil","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0055","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000005500","article-title":"SPECIAL UPDATE: the epidemiology of breast implant associated large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants","author":"Magnusson","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/PRS.0000000000003654","article-title":"Breast implant-associated anaplastic large cell lymphoma in australia and new zealand: high-surface-area textured implants are associated with increased risk","volume":"140","author":"Loch-Wilkinson","year":"2017","journal-title":"Plast Reconstr Surg."},{"key":"10.1016\/j.ctrv.2020.101963_b0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2020.101963_b0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","article-title":"Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases","volume":"135","author":"Brody","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.101963_b0080","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1182\/blood-2018-03-785972","article-title":"How I treat breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Mehta-Shah","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2020.101963_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/gs.2016.11.03","article-title":"Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules","volume":"6","author":"Clemens","year":"2017","journal-title":"Gland Surgery"},{"key":"10.1016\/j.ctrv.2020.101963_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/asj\/sju084","article-title":"Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study","volume":"35","author":"Maxwell","year":"2015","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ctrv.2020.101963_b0095","doi-asserted-by":"crossref","first-page":"e0181097","DOI":"10.1371\/journal.pone.0181097","article-title":"Cytological diagnostic features of late breast implant seromas: from reactive to anaplastic large cell lymphoma","volume":"12","author":"Di Napoli","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctrv.2020.101963_b0100","first-page":"492","article-title":"Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules","volume":"13","author":"Bautista-Quach","year":"2013","journal-title":"Clin Breast Can."},{"key":"10.1016\/j.ctrv.2020.101963_b0105","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1097\/PRS.0000000000005568","article-title":"Characteristics and treatment of advanced breast implant-associated anaplastic large cell lymphoma","volume":"143","author":"Collins","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","article-title":"Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma","volume":"42","author":"Ferrufino-Schmidt","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ctrv.2020.101963_b0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ctrv.2020.101963_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3034-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients","volume":"147","author":"Adrada","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2020.101963_b0125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamasurg.2017.4026","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"152","author":"Leberfinger","year":"2017","journal-title":"JAMA surgery."},{"key":"10.1016\/j.ctrv.2020.101963_b0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/PRS.0000000000000886","article-title":"Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma","volume":"135","author":"Hu","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0135","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1158\/1078-0432.CCR-14-0496","article-title":"Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas","volume":"20","author":"Zucca","year":"2014","journal-title":"Clin Can Res"},{"key":"10.1016\/j.ctrv.2020.101963_b0140","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/1078-0432.CCR-12-0101","article-title":"Survival signals and targets for therapy in breast implant-associated ALK\u2013anaplastic large cell lymphoma","volume":"18","author":"Lechner","year":"2012","journal-title":"Clin Can Res"},{"key":"10.1016\/j.ctrv.2020.101963_b0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/asj\/sjw023","article-title":"Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma","volume":"36","author":"Kadin","year":"2016","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ctrv.2020.101963_b0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humpath.2018.04.007","article-title":"IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis","volume":"78","author":"Kadin","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ctrv.2020.101963_b0155","doi-asserted-by":"crossref","first-page":"471e","DOI":"10.1097\/PRS.0000000000000020","article-title":"In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants","volume":"133","author":"Jacombs","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0160","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PRS.0000000000002010","article-title":"Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma","volume":"137","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjh.14431","article-title":"Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK\/STAT signalling pathway genes, TP53 and DNMT3A","volume":"180","author":"Di Napoli","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ctrv.2020.101963_b0170","doi-asserted-by":"crossref","first-page":"36126","DOI":"10.18632\/oncotarget.26308","article-title":"Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma","volume":"9","author":"Blombery","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2020.101963_b0175","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019001904","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL","author":"Laurent","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2020.101963_b0180","doi-asserted-by":"crossref","DOI":"10.1093\/asj\/sjz021","article-title":"Differences in human leukocyte antigen expression between breast implant-associated ALCL patients and the general population","author":"Tevis","year":"2019","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ctrv.2020.101963_b0185","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41379-018-0130-7","article-title":"Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas","volume":"32","author":"Di Napoli","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctrv.2020.101963_b0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2019.05.007","article-title":"Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas","volume":"90","author":"Tabanelli","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ctrv.2020.101963_b0195","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PAS.0b013e31825749b1","article-title":"Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases","volume":"36","author":"Aladily","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ctrv.2020.101963_b0200","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/cup.12697","article-title":"Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma","volume":"43","author":"Alcala","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ctrv.2020.101963_b0205","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/asj\/sjw286","article-title":"CD30+ T cells in late Seroma May Not Be diagnostic of breast implant-associated anaplastic large cell lymphoma","volume":"37","author":"Kadin","year":"2017","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ctrv.2020.101963_b0210","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2020.101963_b0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1011379725811","article-title":"MUC1, the renaissance molecule","volume":"6","author":"Gendler","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ctrv.2020.101963_b0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAI.0b013e318266476c","article-title":"Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases","volume":"21","author":"Taylor","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"10.1016\/j.ctrv.2020.101963_b0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.leu.2404481","article-title":"Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936","volume":"21","author":"Bruggemann","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2020.101963_b0230","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ctrv.2020.101963_b0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/modpathol.3801024","article-title":"Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder","volume":"21","author":"Roden","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctrv.2020.101963_b0240","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ejso.2017.05.004","article-title":"Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent","volume":"43","author":"Johnson","year":"2017","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Brit Assoc Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.101963_b0245","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ccr3.1382","article-title":"Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma","volume":"6","author":"Alderuccio","year":"2018","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ctrv.2020.101963_b0250","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study","volume":"30","author":"Pro","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.101963_b0255","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/01.prs.0000481103.45976.b1","article-title":"Breast implant informed consent should include the risk of anaplastic large cell lymphoma","volume":"137","author":"Clemens","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0260","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1503\/cmaj.110513","article-title":"Breast reconstruction after mastectomy for breast cancer","volume":"183","author":"Platt","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.ctrv.2020.101963_b0265","first-page":"424","article-title":"Breast reconstruction: updated overview for primary care physicians","volume":"64","author":"Somogyi","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ctrv.2020.101963_b0270","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/PRS.0000000000002536","article-title":"A Comparison of psychological response, body image, sexuality, and quality of life between immediate and delayed autologous tissue breast reconstruction: a prospective long-term outcome study","volume":"138","author":"Zhong","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ctrv.2020.101963_b0275","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/cncr.26417","article-title":"Patient satisfaction and health-related quality of life after autologous tissue breast reconstruction: a prospective analysis of early postoperative outcomes","volume":"118","author":"Zhong","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.101963_b0280","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1245\/s10434-017-6014-0","article-title":"Implications of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) for breast cancer reconstruction: an update for surgical oncologists","volume":"24","author":"O'Neill","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.101963_b0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1207\/s15324796abm3101_8","article-title":"A heuristics approach to understanding cancer risk perception: contributions from judgment and decision-making research","volume":"31","author":"Peters","year":"2006","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.ctrv.2020.101963_b0290","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1467-8721.2006.00461.x","article-title":"Risk perception and affect","volume":"15","author":"Slovic","year":"2006","journal-title":"Curr Dir Psychol Sci"},{"key":"10.1016\/j.ctrv.2020.101963_b0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/a0036834","article-title":"Decision making and cancer","volume":"70","author":"Reyna","year":"2015","journal-title":"Am Psychol"},{"key":"10.1016\/j.ctrv.2020.101963_b0300","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/asj\/sjy009","article-title":"Decisions and incisions: the role of choice architecture in surgical decision making","volume":"38","author":"Offodile","year":"2018","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ctrv.2020.101963_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-0771(200001\/03)13:1<1::AID-BDM333>3.0.CO;2-S","article-title":"The affect heuristic in judgments of risks and benefits","volume":"13","author":"Finucane","year":"2000","journal-title":"J Behav Decis Making"},{"key":"10.1016\/j.ctrv.2020.101963_b0310","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.185.4157.1124","article-title":"Judgment under uncertainty: heuristics and biases","volume":"185","author":"Tversky","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2020.101963_b0315","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/1055-9965.EPI-08-0074","article-title":"Psychologic predictors of cancer information avoidance among older adults: the role of cancer fear and fatalism","volume":"17","author":"Miles","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ctrv.2020.101963_b0320","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/his.12737","article-title":"Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome","volume":"67","author":"Lee","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.ctrv.2020.101963_b0325","first-page":"936","article-title":"Patient decision aids for prevention and treatment of cancer diseases: are they really personalised tools?","volume":"25","author":"Gorini","year":"2016","journal-title":"Eur J Cancer Care (Engl)."},{"key":"10.1016\/j.ctrv.2020.101963_b0330","first-page":"755","article-title":"iManageCancer: Developing a platform for Empowering patients and strengthening self-management in cancer diseases","author":"Kondylakis","year":"2017","journal-title":"Comp Med Sy"},{"key":"10.1016\/j.ctrv.2020.101963_b0335","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2753.2011.01709.x","article-title":"A P5 cancer medicine approach: why personalized medicine cannot ignore psychology","volume":"17","author":"Pravettoni","year":"2011","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.ctrv.2020.101963_b0340","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.breast.2019.01.011","article-title":"EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants","volume":"44","author":"Cardoso","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.ctrv.2020.101963_b0345","unstructured":"D\u00e9cision du 02\/04\/2019 portant interdiction de mise sur le march\u00e9, de distribution, de publicit\u00e9 et d'utilisation d'implants mammaires \u00e0 enveloppe macro-textur\u00e9e et d'implants mammaires polyur\u00e9thane, ainsi que retrait de ces produits. Available at: https:\/\/ansm.sante.fr\/Decisions\/Injonctions-decisions-de-police-sanitaire-sanctions-financieres-interdictions-de-publicite-Decisions-de-police-sanitaire\/Decision-du-02-04-2019-portant-interdiction-de-mise-sur-le-marche-de-distribution-de-publicite-et-d-utilisation-d-implants-mammaires-a-enveloppe-macro-texturee-et-d-implants-mammaires-polyurethane-ainsi-que-retrait-de-ces-produits. Access on 23th April 2019."},{"key":"10.1016\/j.ctrv.2020.101963_b0350","unstructured":"Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure. Available at: https:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2019\/69520a-eng.php. Access on 23th April 2019."},{"key":"10.1016\/j.ctrv.2020.101963_b0355","unstructured":"Statement from FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., and Jeff Shuren, M.D., J.D., director of the FDA\u2019s Center for Devices and Radiological Health on FDA\u2019s new efforts to protect women\u2019s health and help to ensure the safety of breast implants. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/statement-fda-principal-deputy-commissioner-amy-abernethy-md-phd-and-jeff-shuren-md-jd-director-fdas. Access on 5th May 2019."}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T09:21:36Z","timestamp":1759656096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737220300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":71,"alternative-id":["S0305737220300013"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.101963","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast implant-associated anaplastic large cell lymphoma: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.101963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101963"}}